These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2378498)

  • 21. [The use of pentoxifylline in the therapy of torpid malleolar ulcers in thalassemia major].
    Muratore F
    Clin Ter; 1982 Jun; 101(5):493-5. PubMed ID: 7128026
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of skin and muscle biopsies before and after pentoxifylline treatment in patients with leg ulcers due to deep venous incompetence.
    Angelides NS; von der Ahe CW; Themistocleus P
    Int Angiol; 1991; 10(2):72-6. PubMed ID: 1861090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pentoxifylline on treatment of lower limb ulcers in patients with thalassemia major.
    Angelides NS; Angastiniotis C; Pavlides N
    Angiology; 1992 Jul; 43(7):549-54. PubMed ID: 1626732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxpentifylline for venous leg ulcers.
    Drug Ther Bull; 1991 Jul; 29(15):59-60. PubMed ID: 1914868
    [No Abstract]   [Full Text] [Related]  

  • 26. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
    Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline--a prospective study.
    Ott E; Körner E; Lechner H
    Angiology; 1988 Jun; 39(6):520-5. PubMed ID: 3377272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
    Ott E; Lechner H; Fazekas F
    Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche.
    Sauer GC
    Arch Dermatol; 1986 Apr; 122(4):380-1. PubMed ID: 3954406
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of diabetic neuropathy with pentoxifylline: case report.
    Kalmansohn RB; Kalmansohn RW; Markham CH; Schiff DL
    Angiology; 1988 Apr; 39(4):371-4. PubMed ID: 3364803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of trophic ulcers of the lower extremities with Trental-400].
    Koshkin VM; Bogdanets LI; Makarova LD
    Khirurgiia (Mosk); 1996; (1):49-51. PubMed ID: 8683922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W; Leube G
    Med Welt; 1979 Sep; 30(37):1367-9. PubMed ID: 502814
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous pentoxifylline in the treatment of rest pain: a preliminary report.
    McCollum PT; Kent P; O'Driscoll K; Carey D; Stanley ST; Weil von der Ahe CA; Moore DJ; Shanik DG
    Ann Vasc Surg; 1989 Jul; 3(3):220-3. PubMed ID: 2775635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
    Aviado DM; Dettelbach HR
    Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alopecia areata. Hemorheological study and treatment with pentoxifylline].
    Trevisan G; Cisilin MP
    G Ital Dermatol Venereol; 1988 May; 123(5):211-4. PubMed ID: 3209239
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM; Samper JC
    Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
    Müller R; Lebrach F
    Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.